Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Exome Asset Management
Traditional Asset Manager (as LP)
Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices.
Overview and Management
Establishment Year
2018
Mission
Investing for a healthier world by identifying the best and most innovative healthcare investments globally, capitalizing on rapid changes and technological advancements in the healthcare industry.
Values
Diversity, innovation, sound investment strategies, and a commitment to making a positive impact in healthcare.
Investment Roles
Direct Investor
Participant Demographics
Serving accredited and qualified investors.
Generational Wealth Planning
Risk Tolerance
Modest leverage in developed markets and diversified strategies in emerging markets, indicating moderate risk tolerance.
References or Case Studies
Can provide information about specific private investments, such as Centrexion Therapeutics, Impact Therapeutics, and others.
Team Experience
Led by Samuel D. Isaly with 45+ years of experience in healthcare investments.
Notable Achievements
Diversified portfolio in healthcare subsectors and global markets.
Project Track Record
Investments in companies like Centrexion Therapeutics, Impact Therapeutics, New Horizon Health, and others.
Exit Strategies
Legal, Compliance and Contact Information
Regulatory Registrations
Compliance History
info@exomeasset.com
Phone Number
212-403-3900
Address
New York United States